Moreover, WEE1 is associated with cancer progression and highly expressed in breast cancer (Ha et al., 2020), lung cancer (Liu et al., 2019), head and neck cancer (Diab et al., 2019), and ovarian cancer (Zhang et al., 2017). Here, WEE1 is linked to cancer.